![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 47/68 | |
C07K 16/00 | |||
C07K 14/435 |
(11) | Number of the document | 3020418 |
(13) | Kind of document | T |
(96) | European patent application number | 14823791.0 |
Date of filing the European patent application | 2014-07-14 | |
(97) | Date of publication of the European application | 2016-05-18 |
(45) | Date of publication and mention of the grant of the patent | 2020-02-26 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/KR2014/006329 |
Date | 2014-07-14 |
(87) | Number | WO 2015/005748 |
Date | 2015-01-15 |
(30) | Number | Date | Country code |
20130082511 | 2013-07-12 | KR |
(72) |
PARK, Sung Hee, KR
KIM, Min Young, KR
LIM, Hyung Kyu, KR
BAE, Sung Min, KR
JUNG, Sung Youb, KR
KWON, Se Chang, KR
|
(73) |
Hanmi Pharm. Co., Ltd.,
214 Muha-ro Paltan-myeon, Hwaseong-si, Gyeonggi-do 445-958,
KR
|
(54) | CONJUGATE OF BIOLOGICALLY ACTIVE POLYPEPTIDE MONOMER AND IMMUNOGLOBULIN FC FRAGMENT WITH REDUCED RECEPTOR-MEDIATED CLEARANCE, AND THE METHOD FOR PREPARING THE SAME |
CONJUGATE OF BIOLOGICALLY ACTIVE POLYPEPTIDE MONOMER AND IMMUNOGLOBULIN FC FRAGMENT WITH REDUCED RECEPTOR-MEDIATED CLEARANCE, AND THE METHOD FOR PREPARING THE SAME |